Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3999 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.20 USD | -0.83% | +4.35% | +8.11% | -12.41% | 98.73 M USD | ||
| 4004 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.97 USD | -0.67% | -2.94% | +2.41% | +52.31% | 98.66 M USD | ||
| 4019 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.22 USD | -2.06% | +2.55% | +11.54% | +50.87% | 95.02 M USD | ||
| 4021 |  ICCC ImmuCell Corporation - Common Stock | 10.47 USD | +1.26% | -3.06% | +8.05% | +55.34% | 94.72 M USD | ||
| 4027 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.29 USD | -7.86% | -5.15% | +9.32% | -33.16% | 93.27 M USD | ||
| 4028 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.04 USD | -3.70% | -7.96% | -14.05% | +85.71% | 93.08 M USD | ||
| 4037 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.54 USD | -7.02% | -17.90% | -0.42% | -35.32% | 85.96 M USD | ||
| 4048 |  LIXT Lixte Biotechnology Holdings, Inc. - Common Stock | 7.21 USD | 0.00% | +8.10% | +7.45% | +188.40% | 89.28 M USD | ||
| 4057 |  NRXS Neuraxis, Inc. Common Stock | 7.01 USD | -1.54% | -1.96% | +0.72% | +29.10% | 86.81 M USD | ||
| 4061 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.43 USD | -2.72% | +0.70% | +10.00% | -31.25% | 86.95 M USD | ||
| 4064 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.96 USD | -4.95% | -1.03% | +1.05% | -12.73% | 82.12 M USD | ||
| 4073 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.23 USD | -0.81% | -3.15% | -3.91% | +2.50% | 84.59 M USD | ||
| 4076 |  ACET Adicet Bio, Inc. - Common Stock | 9.07 USD | +5.47% | +7.21% | +23.40% | +1177.46% | 84.79 M USD | ||
| 4077 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.24 USD | -8.15% | -3.88% | -17.33% | -69.31% | 84.78 M USD | ||
| 4081 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.68 USD | -4.23% | -11.69% | -19.05% | +7.94% | 84.24 M USD | ||
| 4091 |  RLYB Rallybio Corporation - Common Stock | 15.65 USD | -0.13% | -1.45% | -2.80% | +3030.00% | 82.92 M USD | ||
| 4092 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.93 USD | +3.76% | +10.29% | +34.97% | +46.21% | 82.61 M USD | ||
| 4102 |  CSBR Champions Oncology, Inc. - Common Stock | 5.83 USD | -0.85% | -3.64% | +2.64% | -34.93% | 80.96 M USD | ||
| 4103 |  LONA LeonaBio, Inc. - Common Stock | 8.63 USD | -1.26% | -0.69% | -1.03% | +28.04% | 81.07 M USD | ||
| 4108 |  ENTX Entera Bio Ltd. - Ordinary Shares | 1.68 USD | +1.20% | -8.20% | +38.84% | -6.67% | 82.70 M USD |
Nachrichten Biotechnology Stocks
BofA bestätigt Kaufempfehlung für Beam Therapeutics nach Schiedsspruch
ROUNDUP/Aktien Frankfurt Schluss: Waffenruhe im Iran wohl vorbei - Dax sackt ab
Schiedsspruch belastet Beam Therapeutics: Aktie fällt vom 52-Wochen-Hoch
Prime Medicine: Aktie legt nach Sieg im Rechtsstreit mit Beam Therapeutics deutlich zu
Incyte Aktie erreicht 52-Wochen-Hoch bei 118,77 USD
Prime Medicine Aktie steigt nach gewonnenem Schiedsverfahren gegen Beam
Quartalsbericht von Nurix Therapeutics: Roche-Partnerschaft im Fokus
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
 VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |